One major trial found 9.1% sustained abstinence at 12 months with quit line counseling - not amazing on its own, but a meaningful improvement over going it alone
Phase 3 trials are ongoing and definitive cardiovascular conclusions cannot yet be drawn
By September 2023, the FDA had seized SARMs products from Paradigm to carry out tests on them
All were proposing to clinicians is, Hey, think about the patients who are at risk and have a strategy to monitor and mitigate that risk. Q: What about patients on GLP-1s
Common glimepiride side effects include headache, dizziness, weakness, and hypoglycemia (low blood sugar levels)
Retained gastric contents, increased gastric volume, endoscopy discontinuation, regurgitation, aspiration events, aspiration pneumonitis, aspiration pneumonia, and postoperative respiratory failure are related but not interchangeable endpoints